{"name":"Mithra Pharmaceuticals","slug":"mithra-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPTkRheG11dFNObS1SUFVwcXJXQ1M0QVJpVk1JX2k4VHVKMEJzQTBjQk9GQ0tScWNwUEowXzg0Y3lEQjJKUTlYdjY2Nmd3SUZzVnJSTVk2RmhKSy1oWFk1ZHBIaEQxWU5HRHhFeE15THFwSC1FVmxXZVVuNlZjdWlyMEx6R2dhWXFxalNZRU1fWWNUNENwQmlXanFmcE1yV29lT1EzVmV0ZHFJNzVOQ1ZSaG9lQnVkUEFtS1k4dFQ2bEJoaUwyTUNkWUI2eXFkT1NoMGJLeFhObUlyN04zMUVicTYzSmpYa1FJNC01blBVZGNsTlhMM2lyUzI4SVBjekVwZmNwUWxHUHRVbnB1UnRHdENvS1drSTNkdHpRYkJrSWlPamZmZ2g0d3N3?oc=5","date":"2026-03-12","type":"pipeline","source":"PR Newswire","summary":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight - PR Newswire","headline":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNNXJWYjc1WFJIcE11dTV2UHBrWjJZcl95ak16ODF1SU9Ob1lOb2NYeXhfdGlYQTAtSzA1NFFZbDFTcEUyNjJXU3lQOWlsOEdWZmtaRHpLYnJfWFQtZWYxbWp0a2picTJaNDg2TTl0Q0x2dEFvcDRLMVJFVzUzblRVQ0RYUEtHSW1YNnJrdGl1MWtoZC1TSXBfRk1KU1FyUQ?oc=5","date":"2026-02-24","type":"pipeline","source":"Share Talk","summary":"N4 Pharma plc (AIM: N4P) CEO Appointment & Name Change Thalia Therapeutics - Share Talk","headline":"N4 Pharma plc (AIM: N4P) CEO Appointment & Name Change Thalia Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBlS2d6cHVZWlJSY080cnZ1UTM3aE5WX1FtX05QZVVGOXdDeXlvU282QjBlSFVHX3E3ZkF3Nzl2OHRvZm1JV1FZQmM2ZDlYZXda?oc=5","date":"2025-10-30","type":"pipeline","source":"smallcaps.com.au","summary":"Insights: Mayne Pharma Group Ltd (ASX:MYX) - smallcaps.com.au","headline":"Insights: Mayne Pharma Group Ltd (ASX:MYX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQejN0R3FzV19yUHpkVjFDWW0tWm9pRTY4ekp0Rk1Ca3pSRk0tTXJQaEF2dHpoY2FPRk5sb1JSdTh0d1hGYUcwYnRtWVRUVFV0MlN6bGZVYmRyZ2dBeEVLUmpHMTdTWVozNm0wVTY4b0ZicU42ODNRXzZpMEk4WmZRZU9Qc05RWG91?oc=5","date":"2025-05-12","type":"pipeline","source":"Pharmaceutical Executive","summary":"The Three Pillars of Pharma’s New Commercial Model - Pharmaceutical Executive","headline":"The Three Pillars of Pharma’s New Commercial Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPbmFPNlB4b1lPOXpkV1NZVkRMUDVOR2xGakZaYWxreDNfemN0b1VNV3E4TnplWFVhdzdFaGRlUE9VZmtIRDVsNWhObkRyUEZKbHFoNksxd2E2emtzTkpPeDNyRkpUa01ISl9ySXRLRDNlSDNrVXQ4blFrdklrcUhnZHI4dHZ6ZXJCamIzWjNJWFUyS3ZUaXJmaHpkT0Y1eTdqSUVoa0E2aw?oc=5","date":"2024-06-12","type":"regulatory","source":"Pharmaceutical Technology","summary":"Bankrupt Mithra cashes in on remaining assets for $188.2m - Pharmaceutical Technology","headline":"Bankrupt Mithra cashes in on remaining assets for $188.2m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPdmZ5cmtuUkZTWFdBc0d5VkhFVVF5S3Q5WWhEWE0wdXBDdXQ3THBpaS1FWUhXRklPS2stb0ZXQjlYckYwdkxKOFlUNTFWSUxkdkNmdXV3eGkwb0hSdnQ5OTNSZ19OS3NJOW9HZVpRWHNBZHlIaC1UaF9kV3B3blNpZnMyNGhhT3g1ZkJDSThob09LaU9qOXRxbHJ3RlRUMzBmbS1rQmRVR3BlUlBqUzlReFZtT2U1NFJZNHREeGlUQ2VzLXZWZ3Q1SjZmNA?oc=5","date":"2024-05-31","type":"pipeline","source":"Johns Hopkins Medicine","summary":"Mitra Gavgani Appointed President of Johns Hopkins Care at Home - Johns Hopkins Medicine","headline":"Mitra Gavgani Appointed President of Johns Hopkins Care at Home","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQmMzZDhseGRYQWRVVklkaXRIQ00wVVdFbEtfdnB2WktWWk5YN0Q1RHJCbnVEMnBnYzFCRW1FZWxWZ25sMEdzUXduejZjWFpJQzdGdXo0czBJV2R6MV9HeXRLX0hJRHdXSG5zRktfS0JoTV9sbG5EeHdzOHNlQ1NxZ1ZYMzM2dmR6UkxiZlZSTFNGV1N1Y3pta2lnQjdyTU54dnBOZmYwV3hYZEE?oc=5","date":"2024-02-15","type":"pipeline","source":"globenewswire.com","summary":"Mithra sells shares in Mayne Pharma - globenewswire.com","headline":"Mithra sells shares in Mayne Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNLVQyOGNEQmtOQ1libnFFWHV3WGVqeTh3eWpsWENxaEtjN05lajZpbzR5VExGdS1SZDBkdEpTS1JjT0toUkw5NHBzWDNfRjBfTnI1VHZseHJwZWVyZFVkbFdNZWVuUkZVSmRvWk82X2I0eXFldXRXU0ROdHYwZkx4ZTk3d0ZZYU9KT1RIMHhJZEdsQ3c3M1IyVg?oc=5","date":"2023-11-06","type":"patent","source":"Yahoo Finance UK","summary":"Mithra’s NEXTSTELLIS® granted additional patent in the United States - Yahoo Finance UK","headline":"Mithra’s NEXTSTELLIS® granted additional patent in the United States","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPcV9WaFdmZEVVN1M5MHZrUWJWUEZtUDVhcFR0M3J1X1M3MjhzQXBiSUhHN1ZQbjZpeW5WTENBeWZ5aDVaQXpNNFpncUJjQ2Zsa2pBTXQ1RGMxOUdwOUpOM2JjSVQ3V0JFOVhhRTBfLWJEcjl0WEE5M2lmcmVXNjE1eVF1c2o2Q3VjSVJ5VVNfckxTVlJR?oc=5","date":"2023-08-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment - Pharmaceutical Technology","headline":"Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOVEhJYTBCaUh3ZkZ5MGt3MjV2bjM0NXVNQ3U1SzJCRkwxMkFMS2VMWFJMTEVXLW5ENmZiNHhIMFhBTWp3UGJmeTl0b005ZEo1R002bVhqR29lOFRsd1lCS2Nnc2tTSUR1LWRrYkl1QTd6NHcya3VQUkZpcl9PQ2FmS1JBNmpYMmxZOXZiZDBhY2ZUMHdyXzh3YW5ZakRzMFk?oc=5","date":"2023-07-31","type":"deal","source":"European Biotechnology Magazine","summary":"Mithra Pharmaceuticals SA in €17m licencing deal - European Biotechnology Magazine","headline":"Mithra Pharmaceuticals SA in €17m licencing deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQZjJET3F6OHR4Z2ZWVWZtY3M1LXN3V0VOVW03TzZwLUJPNk5SdVVGcXZGUDZ1a09jYUxaZmkxVnN0QzJEVXRnOXZSZUxSYU5xQzdmWHlDbVlEQTl0Rkg0cnhfR1NXUkdrUXdYQmV6dW5YQ3dUQXdNSGZfMEhqNDNObnF4UVZnOWFzSFVYeV8tYXdGZFJ1WHc?oc=5","date":"2023-06-15","type":"trial","source":"Clinical Trials Arena","summary":"Mithra gears up to enter the immune-oncology race - Clinical Trials Arena","headline":"Mithra gears up to enter the immune-oncology race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5GanpVR0s5YWNwTGtVTFVvWnJOYXhQTFg1Rml6bDJxeEhmV2xsUE5OLVBmeXByRUt3RnhOTTIzYWNoQ3NWZ1JtZ2d3clFaZzNBRjluOFV6UVVEc05xQmc?oc=5","date":"2021-06-28","type":"pipeline","source":"ACS Publications","summary":"Synthesizing a natural product - ACS Publications","headline":"Synthesizing a natural product","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}